Relapsed or refractory Hodgkin lymphoma - pembrolizumab initial PBS authority application form (PB232)
Use this form to apply for initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with pembrolizumab for relapsed or refractory Hodgkin lymphoma.
Download and complete the Relapsed or refractory Hodgkin lymphoma - pembrolizumab initial PBS authority application form.
This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.
You can upload this form in HPOS.
If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.
Page last updated: 1 September 2020
This information was printed 6 January 2021 from https://www.servicesaustralia.gov.au/organisations/health-professionals/forms/pb232. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/individuals/site-notices when using this material.